Disease & disorder
pemphigus vulgaris
MONDO:0008219
Pemphigus is a group of chronic autoimmune skin diseases characterized by blister formations on the outer layer of the skin and the mucous membranes. Three clinical forms have been characterized, of which pemphigus vulgaris is the most frequent (75%).
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Clinical trials
3 shownOpen-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.NCT06581562 · 2024-05-15
RECRUITINGTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesNCT05635266 · 2021-10-26
UNKNOWNCOVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersNCT05000216 · 2021-08-13
TERMINATEDDrugs being studied
Research locations
Ann ArborMichigan, United States1AtlantaGeorgia, United States1BostonMassachusetts, United States1Chapel HillNorth Carolina, United States1CharlestonSouth Carolina, United States1ClevelandOhio, United States1ColumbusOhio, United States1DallasTexas, United States1DurhamNorth Carolina, United States1HoustonTexas, United States1IndianapolisIndiana, United States1Los AngelesCalifornia, United States1
Leading sponsors
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.